Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.92 |
| ▸ | TRIM24 | O15164 | 2/20 | 0.92 |
| ▸ | TRIM33 | Q9UPN9 | 2/20 | 0.92 |
| ▸ | CRBN | Q96SW2 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | FKBP5 | Q13451 | 1/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.32 |
| ▸ | MAOA | P21397 | 1/20 | 0.32 |
| ▸ | MAOB | P27338 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | CA4 | P22748 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | CASP1 | P29466 | 1/20 | 0.30 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3393322 | 1.00 | ALDH1A1 (0.92) | ALDH1A1TRIM24TRIM33CRBNKMT2A | |
| SCHEMBL19187811 | 1.00 | ALDH1A1 (0.92) | ALDH1A1TRIM24TRIM33CRBNKMT2A | |
| SCHEMBL5069700 | 1.00 | ALDH1A1 (0.92) | ALDH1A1TRIM24TRIM33CRBNKMT2A | |
| SCHEMBL3668251 | 1.00 | ALDH1A1 (0.92) | ALDH1A1TRIM24TRIM33CRBNKMT2A | |
| SCHEMBL21925249 | 1.00 | ALDH1A1 (0.92) | ALDH1A1TRIM24TRIM33CRBNKMT2A | |
| SCHEMBL21925250 | 1.00 | ALDH1A1 (0.92) | ALDH1A1TRIM24TRIM33CRBNKMT2A | |
| SCHEMBL25380098 | 0.96 | TRIM24 (1.00) | ALDH1A1TRIM24TRIM33CRBNKMT2A | |
| Cyclohexanone SCHEMBL3299 | 0.96 | — | — | |
| Cyclohexanone SCHEMBL713141 | 0.96 | — | — | |
| SCHEMBL112034 | 0.96 | TRIM24 (1.00) | ALDH1A1TRIM24TRIM33CRBNKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4662194-A1 | NEW METHOD FOR OZONOLYSIS AND REDUCTIVE QUENCHING OF OZONIDES | P2 Science, Inc. (US) | 2025-12-17 | — | — | EP | claimed |
| WO-2024167957-A1 | NEW METHOD FOR OZONOLYSIS AND REDUCTIVE QUENCHING OF OZONIDES | P2 SCIENCE, INC. (US) | 2024-08-15 | — | — | WO | claimed |
| EP-4662194-A1 | NEW METHOD FOR OZONOLYSIS AND REDUCTIVE QUENCHING OF OZONIDES | P2 Science, Inc. (US) | 2025-12-17 | — | — | EP | disclosed |
| WO-2024167957-A1 | NEW METHOD FOR OZONOLYSIS AND REDUCTIVE QUENCHING OF OZONIDES | P2 SCIENCE, INC. (US) | 2024-08-15 | — | — | WO | disclosed |
| US-11840542-B2 | Method for producing cyclic enol ether compound | KAO CORPORATION (JP) | 2023-12-12 | — | — | US | disclosed |
| US-7015358-B2 | Process for the production of ketones | LONZA AG (CH) | 2006-03-21 | — | — | US | disclosed |
| US-20040138506-A1 | Process for the production of ketones | LONZA AG (CH) | 2004-07-15 | — | — | US | disclosed |
| EP-1385812-A1 | PROCESS FOR THE PRODUCTION OF KETONES | LONZA AG (CH) | 2004-02-04 | — | — | EP | disclosed |
| WO-2002088063-A1 | PROCESS FOR THE PRODUCTION OF KETONES | LONZA AG (CH) | 2002-11-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11840542-B2 | Method for producing cyclic enol ether compound | ERG28, ADH1A, SQLE | ALDH1A1 632/4885TRIM24 1205/4885TRIM33 3829/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.